Episurf Medical AB (publ) (STO:EPIS.B)

Sweden · Delayed Price · Currency is SEK

0.0480

-0.0015 (-3.03%)

Mar 9, 2026, 5:29 PM CET

-61.29% (1Y)

Market Cap	134.90M
Revenue (ttm)	20.20M
Net Income (ttm)	-58.20M
Shares Out	2.81B
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,652,980
Average Volume	33,615,607
Open	0.0492
Previous Close	0.0495
Day's Range	0.0456 - 0.0530
52-Week Range	0.0245 - 0.1450
Beta	1.25
RSI	60.11
Earnings Date	Mar 20, 2026

About Episurf Medical AB

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The c... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2008

Employees 18

Stock Exchange Nasdaq Stockholm

Ticker Symbol EPIS.B

Full Company Profile

Financial Performance

In 2025, Episurf Medical AB's revenue was 20.20 million, a decrease of -1.94% compared to the previous year's 20.60 million. Losses were -58.20 million, -23.42% less than in 2024.

Financial Statements

News

There is no news available yet.